HR Execs on the Move

Nuwellis

www.nuwellis.com

 
We are Nuwellis, (Nasdaq: NUWE) formerly CHF Solutions. Our solutions go beyond chronic heart failure, so we`ve rebranded to reflect our therapeutic focus areas: heart failure, critical care, and pediatric fluid imbalance. We are a medical device company dedicated to transforming the lives of patients suffering from fluid overload through science, collaboration, and innovation. Our Aquadex SmartFlow® System gently removes fluid from adult and pediatric patients weighing 20 kg or more. Nuwellis consists of a purpose-driven team that puts patients and their providers at the center of everything we do. This is the new well. And for those whose lives ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.nuwellis.com
  • 12988 Valley View Road
    Eden Prairie, MN USA 55344
  • Phone: 952.345.4200

Executives

Name Title Contact Details
Rob Scott
Chief Financial Officer Profile
Lynn Blake
Chief Financial Officer Profile
Lynn Blake
Chief Financial Officer Profile
George Montague
Chief Financial Officer Profile

Similar Companies

Landauer

Landauer is committed to providing unrivaled radiation monitoring service and to ongoing discovery for improving radiation safety Landauer is the global leader in radiation science and services. We provide tools and support to organizations with potential exposure to ionizing radiation, helping them achieve their radiation safety goals. Our proprietary, state-of-the-art optically stimulated luminescence (OSL) technology enables the most precise measurements possible for occupational radiation monitoring and environmental monitoring and a full range of specialized applications including machine quality assurance and patient radiation monitoring. We back our advanced technology with the most flexible dosimetry programs and best customer service the industry has to offer. While technology continues to advance, one thing is certain with each innovation we must also focus on identifying and mitigating any potential risks related to the benefits. As the first organization to recognize and address radiation risks, and with a sustained history of innovation and dedication unequaled in the industry, LANDAUER is uniquely poised to lead this quest for improved personal and public health and safety across the globe.

Henry Scheinh

Henry Schein, Inc. is the world`s largest provider of health care products and services to office-based dental, animal health and medical practitioners. The Company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. A Fortune 500® Company and a member of the S&P 500® and NASDAQ 100® Indexes, Henry Schein employs more than 21,000 Team Schein Members and serves more than one million customers. The Company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items. The Company also offers its customers exclusive, innovative technology solutions, including practice management software and e-commerce solutions, as well as a broad range of financial services. Headquartered in Melville, N.Y., Henry Schein has operations or affiliates in 32 countries. The Company`s sales reached a record $11.6 billion in 2016, and have grown at a compound annual rate of approximately 15 percent since Henry Schein became a public company in 1995

Siemic

Siemic is a San Jose, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

global choice healthcare

global choice healthcare is a Albuquerque, NM-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Bigfoot Biomedical

Bigfoot Biomedical is a new kind of medical device company developing technologies to significantly reduce the cognitive, emotional, and financial burden of insulin-requiring diabetes.